Breaking News Instant updates and real-time market news.

ZGNX

Zogenix

$16.84 /

+0.83 (+5.18%)

08:10
07/21/21
07/21
08:10
07/21/21
08:10

Zogenix's FINTEPLA recognized by clinicians in editorial

Zogenix announced that its product FINTEPLA oral solution has been recognized by two distinguished clinicians in an Epilepsy & Behavior editorial titled "Raising the Bar: Fenfluramine Sets New Treatment Standards for Dravet Syndrome." In the editorial, the authors, Joseph Sullivan, M.D., of the UCSF Benioff Children's Hospitals, and Helen Cross, M.B.,Ch.B. Ph.D., of the UK's UCL Institute of Child Health, note that the treatment and diagnosis of severe, rare epilepsies such as Dravet syndrome have improved in the U.S. and Europe with earlier accurate diagnosis, better access to a network of specialized medical care, and availability of new medications. In particular, they note that FINTEPLA has achieved responder rates for seizure reduction at the greater than/=75% level that were previously only observed at the greater than/= 50% level. In their assessment, the authors write that future Dravet syndrome treatments "should be evaluated against the demonstrated efficacy of fenfluramine." FINTEPLA was approved in the U.S. and European Union in 2020 for the treatment of seizures associated with Dravet syndrome patients aged two years and older. The authors write that the novel outcomes reported with FINTEPLA treatment, such as effects on executive functions, have effectively raised the bar for assessment of future therapies. Their opinion is based on the body of previously released data from the clinical trials that supported the U.S. and EU regulatory reviews, as well as data from patients treated up to three years in an ongoing open-label study and in early access programs. Across studies, the data demonstrate that FINTEPLA provides safe, effective, and durable seizure reduction for a majority of treated Dravet syndrome patients, including those who, prior to treatment with FINTEPLA, had continued to experience a high seizure burden despite treatment with one or more other antiepileptic medicines.Across studies, FINTEPLA has been generally well-tolerated, with no observed cases of pulmonary arterial hypertension or valvular heart disease. The most common adverse events were reported as decreased appetite, fatigue, diarrhea, and pyrexia.

ZGNX Zogenix
$16.84 /

+0.83 (+5.18%)

05/07/21 Mizuho
Zogenix shares at 'very attractive entry point,' says Mizuho
04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho

TODAY'S FREE FLY STORIES

Hot Stocks
IBM to automate 22 wheat silos across Egypt » 05:33
09/27/21
09/27
05:33
09/27/21
05:33
IBM

IBM

$137.46 /

+0.725 (+0.53%)

IBM, in collaboration…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IBM IBM
$137.46 /

+0.725 (+0.53%)

IBM IBM
$137.46 /

+0.725 (+0.53%)

07/20/21
Fly Intel: Top five analyst upgrades
07/20/21 Morgan Stanley
IBM price target raised to $164 from $152 at Morgan Stanley
07/20/21 Citi
IBM price target raised to $150 from $140 at Citi
07/20/21 Societe Generale
IBM upgraded to Hold from Sell at Societe Generale
IBM IBM
$137.46 /

+0.725 (+0.53%)

IBM IBM
$137.46 /

+0.725 (+0.53%)

IBM IBM
$137.46 /

+0.725 (+0.53%)

IBM IBM
$137.46 /

+0.725 (+0.53%)

Upgrade
KBC Group upgraded to Buy from Hold at Kepler Cheuvreux » 05:30
09/27/21
09/27
05:30
09/27/21
05:30
KBCSY

KBC Group

$42.81 /

+0.5 (+1.18%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KBCSY KBC Group
$42.81 /

+0.5 (+1.18%)

09/13/21 UBS
KBC Group price target raised to EUR 60 from EUR 57 at UBS
08/18/21 Morgan Stanley
KBC Group price target raised to EUR 81 from EUR 77 at Morgan Stanley
08/06/21 JPMorgan
KBC Group price target raised to EUR 79 from EUR 72 at JPMorgan
08/06/21 RBC Capital
KBC Group price target raised to EUR 73 from EUR 70 at RBC Capital
Hot Stocks
Evelo Biosciences announces data from EDP1815 study » 05:29
09/27/21
09/27
05:29
09/27/21
05:29
EVLO

Evelo Biosciences

$7.25 /

-0.19 (-2.55%)

Evelo Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVLO Evelo Biosciences
$7.25 /

-0.19 (-2.55%)

EVLO Evelo Biosciences
$7.25 /

-0.19 (-2.55%)

07/30/21 Chardan
Evelo Biosciences price target lowered to $12 from $15 at Chardan
07/22/21 JMP Securities
Seres trial news 'disappointing,' but an isolated story, says JMP
07/09/21 Chardan
Evelo Biosciences assumed with a Neutral at Chardan
06/23/21 JMP Securities
JMP raises Evelo Biosciences price target to $38 after Rapt reports data
EVLO Evelo Biosciences
$7.25 /

-0.19 (-2.55%)

  • 29
    Jan
Initiation
Silvergate Capital initiated with an Overweight at Morgan Stanley » 05:28
09/27/21
09/27
05:28
09/27/21
05:28
SI

Silvergate Capital

$103.72 /

-1.45 (-1.38%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SI Silvergate Capital
$103.72 /

-1.45 (-1.38%)

SI Silvergate Capital
$103.72 /

-1.45 (-1.38%)

09/22/21 Wedbush
Silvergate Capital price target lowered to $160 from $175 at Wedbush
06/14/21 Goldman Sachs
Silvergate Capital initiated with a Neutral at Goldman Sachs
05/19/21 Wedbush
Silvergate Capital added to Best Ideas List at Wedbush
04/13/21 Barclays
Silvergate Capital price target raised to $165 from $85 at Barclays
SI Silvergate Capital
$103.72 /

-1.45 (-1.38%)

  • 22
    Jan
SI Silvergate Capital
$103.72 /

-1.45 (-1.38%)

SI Silvergate Capital
$103.72 /

-1.45 (-1.38%)

Initiation
Airbnb initiated with a Neutral at JPMorgan » 05:26
09/27/21
09/27
05:26
09/27/21
05:26
ABNB

Airbnb

$175.86 /

+0.75 (+0.43%)

JPMorgan analyst Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABNB Airbnb
$175.86 /

+0.75 (+0.43%)

ABNB Airbnb
$175.86 /

+0.75 (+0.43%)

09/15/21 Tigress Financial
Airbnb shares going to $206 in 12 months, says Tigress Financial
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Airbnb initiated with a Sell at Goldman Sachs
09/13/21 Goldman Sachs
Airbnb initiated with a Sell at Goldman Sachs
ABNB Airbnb
$175.86 /

+0.75 (+0.43%)

  • 10
    Dec
ABNB Airbnb
$175.86 /

+0.75 (+0.43%)

ABNB Airbnb
$175.86 /

+0.75 (+0.43%)

ABNB Airbnb
$175.86 /

+0.75 (+0.43%)

Hot Stocks
Markel, MCIM announce buy-out transaction for return of NAV in two funds » 05:26
09/27/21
09/27
05:26
09/27/21
05:26
MKL

Markel

$1,226.29 /

+14.91 (+1.23%)

Markel and Markel CATCo,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MKL Markel
$1,226.29 /

+14.91 (+1.23%)

MKL Markel
$1,226.29 /

+14.91 (+1.23%)

04/13/21 Truist
Markel price target lowered to $1,150 from $1,350 at Truist
02/04/21 Deutsche Bank
Markel price target raised to $1,125 from $1,100 at Deutsche Bank
01/06/21 Truist
Markel price target raised to $1,150 from $1,050 at Truist
10/29/20 Deutsche Bank
Markel price target raised to $1,100 from $925 at Deutsche Bank
MKL Markel
$1,226.29 /

+14.91 (+1.23%)

Upgrade
Viant upgraded to Outperform from Market Perform at JMP Securities » 05:24
09/27/21
09/27
05:24
09/27/21
05:24
DSP

Viant

$12.65 /

-0.03 (-0.24%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DSP Viant
$12.65 /

-0.03 (-0.24%)

DSP Viant
$12.65 /

-0.03 (-0.24%)

09/22/21 Berenberg
Viant initiated with a Buy at Berenberg
08/13/21 Canaccord
Viant price target lowered to $38 from $48 at Canaccord
07/30/21 BofA
Viant upgraded to Buy from Neutral at BofA
07/30/21 BofA
Viant upgraded to Buy from Neutral at BofA
DSP Viant
$12.65 /

-0.03 (-0.24%)

  • 10
    Feb
DSP Viant
$12.65 /

-0.03 (-0.24%)

Upgrade
Box upgraded to Outperform from Market Perform at JMP Securities » 05:22
09/27/21
09/27
05:22
09/27/21
05:22
BOX

Box

$25.23 /

+0.55 (+2.23%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOX Box
$25.23 /

+0.55 (+2.23%)

BOX Box
$25.23 /

+0.55 (+2.23%)

07/21/21 RBC Capital
Box initiated with an Underperform at RBC Capital
04/09/21 DA Davidson
Box price target lowered to $22 from $25 at DA Davidson
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
BOX Box
$25.23 /

+0.55 (+2.23%)

BOX Box
$25.23 /

+0.55 (+2.23%)

BOX Box
$25.23 /

+0.55 (+2.23%)

BOX Box
$25.23 /

+0.55 (+2.23%)

Hot Stocks
Medtronic announces first Asia-Pacific procedure with Hugo RAS system » 05:19
09/27/21
09/27
05:19
09/27/21
05:19
MDT

Medtronic

$130.05 /

-0.655 (-0.50%)

Medtronic and Apollo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDT Medtronic
$130.05 /

-0.655 (-0.50%)

MDT Medtronic
$130.05 /

-0.655 (-0.50%)

09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/27/21 Argus
Medtronic price target raised to $165 from $150 at Argus
08/25/21 Truist
Medtronic price target raised to $148 from $138 at Truist
08/25/21 Credit Suisse
Medtronic price target raised to $146 from $137 at Credit Suisse
MDT Medtronic
$130.05 /

-0.655 (-0.50%)

MDT Medtronic
$130.05 /

-0.655 (-0.50%)

MDT Medtronic
$130.05 /

-0.655 (-0.50%)

MDT Medtronic
$130.05 /

-0.655 (-0.50%)

Hot Stocks
InterDigital appoints Rob Stien chief communications and public policy officer » 05:16
09/27/21
09/27
05:16
09/27/21
05:16
IDCC

InterDigital

$69.18 /

+0.16 (+0.23%)

InterDigital announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IDCC InterDigital
$69.18 /

+0.16 (+0.23%)

IDCC InterDigital
$69.18 /

+0.16 (+0.23%)

08/03/21 Roth Capital
Court ruling sets tone for unlicensed Chinese OEMs in Europe, says Roth Capital
03/18/21 B. Riley Securities
B. Riley keeps Buy on InterDigital, still sees renewal opportunity with LG
02/19/21 B. Riley Securities
InterDigital price target raised to $123 from $100 at B. Riley Securities
10/08/20 B. Riley Securities
InterDigital settlement with Lenovo now more likely, says B. Riley Securities
IDCC InterDigital
$69.18 /

+0.16 (+0.23%)

IDCC InterDigital
$69.18 /

+0.16 (+0.23%)

Hot Stocks
AGM Group Holdings, HighSharp enter strategic partnership and potential JV » 05:14
09/27/21
09/27
05:14
09/27/21
05:14
AGMH

AGM Group Holdings

$8.99 /

+0.175 (+1.99%)

AGM Group Holdings and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGMH AGM Group Holdings
$8.99 /

+0.175 (+1.99%)

Upgrade
West China Cement upgraded to Buy from Hold at DBS Bank » 05:10
09/27/21
09/27
05:10
09/27/21
05:10
WCHNF

West China Cement

/

+

DBS Bank analyst Duncan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WCHNF West China Cement
/

+

03/01/21 DBS Bank
West China Cement downgraded to Hold from Buy at DBS Bank
Upgrade
Securitas upgraded to Buy from Hold at SEB Equities » 05:09
09/27/21
09/27
05:09
09/27/21
05:09
SCTBF

Securitas

$16.68 /

+ (+0.00%)

SEB Equities analyst Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCTBF Securitas
$16.68 /

+ (+0.00%)

05:05 Today Credit Suisse
Securitas upgraded to Outperform from Neutral at Credit Suisse
08/17/21 Morgan Stanley
Securitas price target raised to SEK 125 from SEK 118 at Morgan Stanley
08/05/21 RBC Capital
Securitas price target raised to SEK 120 from SEK 110 at RBC Capital
08/05/21 Credit Suisse
Securitas price target raised to SEK 165 from SEK 150 at Credit Suisse
Hot Stocks
Astellas Pharma, Seagen receive approval for Padcev in Japan » 05:09
09/27/21
09/27
05:09
09/27/21
05:09
ALPMY

Astellas Pharma

$17.15 /

+0.0505 (+0.30%)

, SGEN

Seagen

$161.22 /

-4.87 (-2.93%)

Astellas Pharma (ALPMY)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALPMY Astellas Pharma
$17.15 /

+0.0505 (+0.30%)

SGEN Seagen
$161.22 /

-4.87 (-2.93%)

ALPMY Astellas Pharma
$17.15 /

+0.0505 (+0.30%)

06/29/21 Jefferies
Astellas Pharma downgraded to Hold from Buy at Jefferies
10/13/20 JMP Securities
Seagen price target raised to $216 from $200 at JMP Securities
SGEN Seagen
$161.22 /

-4.87 (-2.93%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
SGEN Seagen
$161.22 /

-4.87 (-2.93%)

SGEN Seagen
$161.22 /

-4.87 (-2.93%)

Upgrade
Ferrexpo upgraded to Neutral from Sell at Citi » 05:08
09/27/21
09/27
05:08
09/27/21
05:08
FEEXF

Ferrexpo

$4.12 /

+ (+0.00%)

Citi analyst Ephrem Ravi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FEEXF Ferrexpo
$4.12 /

+ (+0.00%)

09/22/21 BofA
Ferrexpo downgraded to Underperform from Neutral at BofA
09/14/21 Barclays
Ferrexpo price target lowered to 280 GBp from 300 GBp at Barclays
09/13/21 JPMorgan
Ferrexpo price target lowered to 370 GBp from 390 GBp at JPMorgan
05/13/21 Credit Suisse
Ferrexpo price target raised to 500 GBp from 470 GBp at Credit Suisse
Upgrade
Kumba Iron Ore upgraded to Neutral from Sell at Citi » 05:07
09/27/21
09/27
05:07
09/27/21
05:07
KIROY

Kumba Iron Ore

$11.48 /

+ (+0.00%)

Citi analyst Ephrem Ravi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KIROY Kumba Iron Ore
$11.48 /

+ (+0.00%)

09/22/21 BofA
Kumba Iron Ore downgraded to Underperform from Neutral at BofA
Upgrade
Securitas upgraded to Outperform from Neutral at Credit Suisse » 05:05
09/27/21
09/27
05:05
09/27/21
05:05
SCTBF

Securitas

$16.68 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCTBF Securitas
$16.68 /

+ (+0.00%)

08/17/21 Morgan Stanley
Securitas price target raised to SEK 125 from SEK 118 at Morgan Stanley
08/05/21 RBC Capital
Securitas price target raised to SEK 120 from SEK 110 at RBC Capital
08/05/21 Credit Suisse
Securitas price target raised to SEK 165 from SEK 150 at Credit Suisse
05/21/21 Jefferies
Securitas downgraded to Hold from Buy at Jefferies
Upgrade
Icon upgraded to Overweight from Neutral at JPMorgan » 05:04
09/27/21
09/27
05:04
09/27/21
05:04
ICLR

Icon

$282.87 /

+1.29 (+0.46%)

, PRAH

PRA Health

$165.23 /

+ (+0.00%)

JPMorgan analyst Tycho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ICLR Icon
$282.87 /

+1.29 (+0.46%)

PRAH PRA Health
$165.23 /

+ (+0.00%)

ICLR Icon
$282.87 /

+1.29 (+0.46%)

09/14/21 Jefferies
Icon price target raised to $302 from $276 at Jefferies
08/04/21 Credit Suisse
Icon assumed with an Outperform at Credit Suisse
07/26/21 Deutsche Bank
Icon price target raised to $234 from $212 at Deutsche Bank
07/23/21 Citi
Icon upgraded to Buy from Neutral at Citi
PRAH PRA Health
$165.23 /

+ (+0.00%)

07/23/21 Citi
Icon upgraded to Buy from Neutral at Citi
07/23/21 Wells Fargo
Icon price target raised to $280 from $250 at Wells Fargo
05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
ICLR Icon
$282.87 /

+1.29 (+0.46%)

PRAH PRA Health
$165.23 /

+ (+0.00%)

ICLR Icon
$282.87 /

+1.29 (+0.46%)

PRAH PRA Health
$165.23 /

+ (+0.00%)

Downgrade
Talis Biomedical downgraded to Underweight from Neutral at JPMorgan » 05:02
09/27/21
09/27
05:02
09/27/21
05:02
TLIS

Talis Biomedical

$7.05 /

-0.22 (-3.03%)

JPMorgan analyst Tycho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TLIS Talis Biomedical
$7.05 /

-0.22 (-3.03%)

TLIS Talis Biomedical
$7.05 /

-0.22 (-3.03%)

08/31/21 BTIG
Talis Biomedical downgraded to Neutral at BTIG following CEO departure
08/31/21 BTIG
Talis Biomedical downgraded to Neutral from Buy at BTIG
08/12/21 Piper Sandler
Talis Biomedical downgraded to Neutral from Overweight at Piper Sandler
08/11/21 JPMorgan
Talis Biomedical downgraded to Neutral at JPMorgan after launch push-outs
TLIS Talis Biomedical
$7.05 /

-0.22 (-3.03%)

  • 12
    Feb
TLIS Talis Biomedical
$7.05 /

-0.22 (-3.03%)

Downgrade
Zymergen downgraded to Underweight from Neutral at JPMorgan » 04:58
09/27/21
09/27
04:58
09/27/21
04:58
ZY

Zymergen

$13.40 /

-0.405 (-2.93%)

JPMorgan analyst Tycho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZY Zymergen
$13.40 /

-0.405 (-2.93%)

ZY Zymergen
$13.40 /

-0.405 (-2.93%)

08/31/21
Fly Intel: Top five analyst downgrades
08/31/21 UBS
Zymergen downgraded to Neutral from Buy at UBS
08/04/21
Fly Intel: Top five analyst downgrades
08/04/21 Cowen
Cowen downgrades Zymergen on changes pending further information
ZY Zymergen
$13.40 /

-0.405 (-2.93%)

  • 22
    Apr
ZY Zymergen
$13.40 /

-0.405 (-2.93%)

ZY Zymergen
$13.40 /

-0.405 (-2.93%)

ZY Zymergen
$13.40 /

-0.405 (-2.93%)

Upgrade
Adyen upgraded to Outperform from Neutral at Oddo BHF » 04:56
09/27/21
09/27
04:56
09/27/21
04:56
ADYEY

Adyen

$31.35 /

-0.98 (-3.03%)

Oddo BHF analyst Cor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADYEY Adyen
$31.35 /

-0.98 (-3.03%)

09/08/21 Exane BNP Paribas
Adyen upgraded to Outperform from Neutral at Exane BNP Paribas
08/23/21 Deutsche Bank
Adyen price target raised to EUR 2,550 from EUR 2,100 at Deutsche Bank
08/20/21 UBS
Adyen price target raised to EUR 2,853 from EUR 2,617 at UBS
08/20/21 Morgan Stanley
Adyen price target raised to EUR 2,265 from EUR 2,155 at Morgan Stanley
Downgrade
Zalando downgraded to Neutral from Buy at BofA » 04:55
09/27/21
09/27
04:55
09/27/21
04:55
ZLNDY

Zalando

$49.84 /

-1.695 (-3.29%)

BofA analyst Geoffroy de…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZLNDY Zalando
$49.84 /

-1.695 (-3.29%)

08/09/21 Berenberg
Zalando price target raised to EUR 92 from EUR 86 at Berenberg
08/06/21 JPMorgan
Zalando price target raised to EUR 107 from EUR 100 at JPMorgan
07/26/21 UBS
Zalando price target raised to EUR 122 from EUR 118 at UBS
07/12/21 Deutsche Bank
Zalando price target raised to EUR 120 from EUR 112 at Deutsche Bank
ZLNDY Zalando
$49.84 /

-1.695 (-3.29%)

Conference/Events
Flushing Financial management to meet virtually with Truist » 04:55
09/27/21
09/27
04:55
09/27/21
04:55
FFIC

Flushing Financial

$22.37 /

+0.17 (+0.77%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FFIC Flushing Financial
$22.37 /

+0.17 (+0.77%)

FFIC Flushing Financial
$22.37 /

+0.17 (+0.77%)

03/19/21 DA Davidson
Flushing Financial initiated with a Neutral at DA Davidson
03/19/21 DA Davidson
Flushing Financial initiated with a Neutral at DA Davidson
FFIC Flushing Financial
$22.37 /

+0.17 (+0.77%)

Conference/Events
Replimune Group management to meet virtually with BTIG » 04:55
09/27/21
09/27
04:55
09/27/21
04:55
REPL

Replimune Group

$32.27 /

-1.41 (-4.19%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REPL Replimune Group
$32.27 /

-1.41 (-4.19%)

REPL Replimune Group
$32.27 /

-1.41 (-4.19%)

06/11/21 BMO Capital
Replimune Group coverage transferred at BMO Capital
04/19/21 Piper Sandler
Oncorus selloff has nothing to do with fundamentals, says Piper Sandler
02/05/21 H.C. Wainwright
Replimune Group price target raised to $60 from $58 at H.C. Wainwright
12/16/20 Wedbush
Replimune Group, Harpoon Therapeutics removed from Best Ideas List at Wedbush
REPL Replimune Group
$32.27 /

-1.41 (-4.19%)

  • 22
    Oct
Conference/Events
The Real Brokerage Inc. management to meet virtually with Roth Capital » 04:55
09/27/21
09/27
04:55
09/27/21
04:55
REAX

The Real Brokerage Inc.

$1.85 /

-0.02 (-1.07%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REAX The Real Brokerage Inc.
$1.85 /

-0.02 (-1.07%)

REAX The Real Brokerage Inc.
$1.85 /

-0.02 (-1.07%)

08/09/21 Roth Capital
The Real Brokerage Inc. initiated with a Buy at Roth Capital

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.